Upon retiring from Pfizer Inc. after a distinguished 30 year career, Jack joined Oligomerix, Inc. as a Director and Chief Commercial Officer in 2010. OLIGOMERIX is a biopharmaceutical company located in New York City focused on early stage drug discovery targeting tau protease in Alzheimer’s disease. At Pfizer, Jack gained broad commercial leadership experience across a range of responsibilities. For eight years prior to retiring, Jack was Vice-President, Worldwide Marketing responsible for Pfizer’s Global Infectious Diseases and Respiratory Therapeutic Groups. Jack’s other responsibilities included three years as Vice-President of Business Intelligence & Planning and a year as Pfizer’s Regional President of the Africa, Middle East Region. In 1997 Jack was appointed Vice President Product Development. Jack graduated from Merrimack College with a BS in Business Administration and earned an MBA from Fairleigh Dickinson University in New Jersey.